Entero Therapeutics, Inc.
ENTO
$0.3541
-$0.0241-6.37%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 163.50K | 366.80K | 662.50K | 3.43M | 3.71M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 145.30K | 305.50K | 554.40K | 4.06M | 1.24M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 83.17M | 83.17M | 83.17M | -- | -- |
| Total Current Assets | 83.48M | 83.84M | 84.39M | 7.49M | 4.96M |
|
|
|||||
| Total Current Assets | 83.48M | 83.84M | 84.39M | 7.49M | 4.96M |
| Net Property, Plant & Equipment | 126.80K | 144.40K | 163.10K | 207.20K | 210.00K |
| Long-term Investments | 1.68M | 1.68M | 1.68M | 20.04M | 1.68M |
| Goodwill | 1.68M | 1.68M | 1.68M | 20.04M | 1.68M |
| Total Other Intangibles | -- | -- | -- | 365.50K | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 119.80K | 149.80K | 53.30K | 63.03M | 32.80K |
| Total Assets | 85.41M | 85.82M | 86.29M | 91.13M | 6.88M |
|
|
|||||
| Total Accounts Payable | 2.96M | 2.21M | 2.01M | 2.00M | 554.30K |
| Total Accrued Expenses | 252.00K | 219.20K | 1.82M | 2.55M | 825.30K |
| Short-term Debt | -- | -- | 177.60K | 386.80K | 612.80K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 81.50K | 79.50K | 77.40K | 71.20K | 67.10K |
| Total Finance Division Other Current Liabilities | 24.25M | 13.18M | 11.29M | 1.16M | 1.07M |
| Total Other Current Liabilities | 24.25M | 13.18M | 11.29M | 1.16M | 1.07M |
| Total Current Liabilities | 27.55M | 15.69M | 15.38M | 6.17M | 3.13M |
|
|
|||||
| Total Current Liabilities | 27.55M | 15.69M | 15.38M | 6.17M | 3.13M |
| Long-Term Debt | -- | -- | -- | 6.40M | -- |
| Short-term Debt | -- | -- | 177.60K | 386.80K | 612.80K |
| Capital Leases | 59.00K | 80.20K | 101.00K | 127.60K | 146.90K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | 571.20K | -- |
| Total Liabilities | 27.61M | 15.77M | 15.49M | 13.27M | 3.28M |
|
|
|||||
| Common Stock & APIC | 198.51M | 198.52M | 196.69M | 194.94M | 187.93M |
| Retained Earnings | -202.39M | -190.15M | -187.57M | -178.76M | -184.33M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -3.88M | 8.37M | 9.12M | 16.18M | 3.60M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 61.68M | 61.68M | 61.68M | 61.68M | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 61.68M | 61.68M | 61.68M | 61.68M | -- |
|
|
|||||
| Total Common Equity | -3.88M | 8.37M | 9.12M | 16.18M | 3.60M |
| Total Preferred Equity | 61.68M | 61.68M | 61.68M | 61.68M | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 57.80M | 70.05M | 70.80M | 77.86M | 3.60M |
|
|
|||||